Clinical Trial Detail

NCT ID NCT03432897
Title BrUOG 337: Olaparib Prior to Radical Prostatectomy For Patients With Locally Advanced Prostate Cancer and Defects in DNA Repair Genes (337)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements Yes
Sponsors Dr Anthony Mega
Indications

prostate adenocarcinoma

Therapies

Olaparib

Age Groups: senior adult

Additional content available in CKB BOOST